Navigation Links
Toward new medications for chronic brain diseases
Date:4/20/2011

A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's and Huntington's disease. They report on the substance, which blocks formation of cholesterol in the brain, in the journal, ACS Chemical Biology.

Aleksey G. Kazantsev and colleagues previously discovered that blocking cholesterol formation in the brain could protect against some of the damage caused by chronic brain disorders like Parkinson's disease. Several other studies have suggested that too much cholesterol may kill brain cells in similar neurodegenerative diseases. So they launched a search for a so-called "small molecules" substances ideal for developing into medicines capable of blocking formation of cholesterol.

They describe discovery of a small molecule that blocks the activity of a key protein involved in cholesterol production. It successfully lowered cholesterol levels in isolated nerve cells and brain slices from mice. If the molecule proves to be a good target for developing new drugs, the scientists note, "it could have a broader application in other neurological conditions, such as Alzheimer's disease, for which modulation of cholesterol and other associated metabolic pathways might be of therapeutic benefit."


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Toward a more efficient use of solar energy
2. Toward a green grid for delivering solar and wind-based electricity
3. Progress toward the clinical application of autologous induced pluripotent stem cells and gene repair therapy for treatment of familial hypercholesterolemia
4. An advance toward blood transfusions that require no typing
5. Its time to take a unified approach toward measuring sustainability
6. Green chemistry offers route towards zero-waste production
7. Researchers working toward automating sedation in intensive care units
8. A nanoscale rope, and another step toward complex nanomaterials that assemble themselves
9. Toward controlling fungus that caused Irish potato famine
10. Big city life may make residents lean toward green, study says
11. Tracing microbes between individuals towards personalized oral health care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/18/2016)... 18, 2016 --> ... ICT, Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance ... in the border security market and the continuing migration crisis ... Europe has led visiongain to publish this ... --> defence & security companies in the ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... ) - --> - Renvoi : image ... --> --> ... biométriques, fournit de nouveaux lecteurs d,empreintes digitales pour ... de DERMALOG sera utilisé pour produire des cartes ...
(Date:3/9/2016)... -- This BCC Research report provides an overview of ... (RNA Seq) market for the years 2015, 2016 and ... data analysis, and services. Use this report ... such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, ... segment and forecast their market growth, future trends and ...
Breaking Biology News(10 mins):
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels ... Award to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... by one of ACA’s member angel groups. It is the highest honor available for ...
(Date:5/18/2016)... ... 18, 2016 , ... Every day, more than 5,400 ER ... Costing more than $56 billion in direct costs annually, asthma remains a critical ... the suffering associated with uncontrolled asthma can be overwhelmingly disproportionate and better managed,” ...
(Date:5/17/2016)... ... May 17, 2016 , ... ... animal waste reduction applications, announced today it will be showcasing ManureMagic™ at booth ... ManureMagic™ was featured in the Wall Street Journal last year and more recently ...
(Date:5/17/2016)... , May 17, 2016 ... located in Basel, Switzerland ... oral inhibitor of P38 mitogen-activated protein kinase. ... Strekin will build the necessary research ... indications in which MAP Kinases play fundamental roles. ...
Breaking Biology Technology: